Palliation of Dyspnea With Mouth Piece Ventilation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-01

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with incurable advanced disease. Subjects are recruited from a local Hospice and from oncology ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Palliative Oxygen for the Relief of Breathlessness

NCT00327873

Dyspnea

COMPLETED NA

Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

NCT07308171

Ventilated Patients

NOT_YET_RECRUITING NA

Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience

NCT05416437

Dyspnea

ACTIVE_NOT_RECRUITING NA

Evaluation of Different Continuous Positive Airway Pressure (CPAP) Systems in Patients With Acute Respiratory Failure

NCT00876473

Acute Respiratory Failure

COMPLETED

Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease

NCT02278107

Chronic Obstructive Lung Disease Interstitial Lung Disease

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyspnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MPV arm

Subjects use mouth piece ventilation (MPV) accoring to their will to alleviate dyspnea for 24 hours.

Group Type OTHER

Trilogy 100 ® (Philips Respironics)

Intervention Type DEVICE

Trilogy 100 ® (Philips Respironics) on MPV mode.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trilogy 100 ® (Philips Respironics)

Trilogy 100 ® (Philips Respironics) on MPV mode.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mouth piece ventilation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)
* incurable advanced disease
* able to understand the study and to give informed consent
* would not gain from intensive care or resuscitation according to the treating physician

Exclusion Criteria

* unable to participate and use MPV due to e.g. delirium or lack of co-operation
* the cause of the dyspnea can be succesfully treated
* unable to give informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No